Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Eur Acad Dermatol Venereol. 2018 Apr 17;32(11):1893–1896. doi: 10.1111/jdv.14952

Table 2.

Odds Ratios (ORs) and 95% CI for skin cancer with Alzheimer’s disease (AD) and variables used in the adjusted analyses: age, gender, race, cerebrovascular disease (CD), peripheral vascular disease (PVD) and diabetes mellitus (DM).

ORs (95%CI)
AD
Malignant Melanoma 0.39 (0.16–0.97)
Gender 1.22 (1.07–1.41)
Race 1.37 (0.18–10.47)
Age 1.12 (1.11–1.14)
CD 3.68 (3.19–4.25)
PVD 0.74 (0.62–0.88
DM 0.59 (0.08–4.37)
Basal Cell Carcinoma 0.18 (0.07–0.45)
Gender 1.22 (1.06–1.40)
Race 1.43(0.19–10.91)
Age 1.12 (1.11–1.14)
CD 3.69 (3.19–4.26)
PVD 0.74 (0.62–0.88)
DM 0.59 (0.08–4.33)
Squamous Cell Carcinoma 0.08 (0.01–0.59)
Gender 1.22 (1.06–1.40)
Race 1.4 (0.18–10.64)
Age 1.12 (1.11–1.14)
CD 3.68 (3.19–4.26)
PVD 0.74 (0.62–0.88)
DM 0.60 (0.08–4.38)